Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Paroxysmal nocturnal hemoglobinuria–related thrombosis in the era of novel therapies: a 2043-patient-year analysis

Carmelo Gurnari, Hussein Awada, Simona Pagliuca, Danai Dima, Fauzia Ullah, Naomi Kawashima, Yasuo Kubota, Ceylan Colak, Valeria Visconte, Bhumika J. Patel, Vikram Dhillon, Naimisha Marneni, Suresh Kumar Balasubramanian, Ashwin Kishtagari, Taha Bat, Jaroslaw P. Maciejewski

Blood (2024) 144 (2): 145–155.

https://doi.org/10.1182/blood.2024023988

Published: 2024

Journal Articles

Can Emergency Hematopoiesis Due to Sepsis Lead to Clonal Hematopoiesis? Implications for Understanding the Pathogenesis of Clonal Evolution

Olisaemeka Ogbue, Tariq Kewan, Omar Mehkri, Francois Fadell, Ishani Nautiyal, Megan Reynold, Arda Durmaz, Jennifer VanOudenhove, Hussein Awada, Serhan Unlu, Abhay Singh, Valeria Visconte, Lourdes Mendez, David S. Bosler, Abhijit Duggal, Stephanie Halene, Jaroslaw P. Maciejewski, Mohammed J Al-Jaghbeer, Carmelo Gurnari

Blood (2023) 142 (Supplement 1): 2691.

https://doi.org/10.1182/blood-2023-187424

Published: 2023

Journal Articles

Molecular Landscape of c-CBL Mutation in Adults' Myeloid Malignancies

Luca Guarnera, Carmelo Gurnari, Carlos Bravo-Perez, Arda Durmaz, Nakisha D Williams, Hussein Awada, Naomi Kawashima, Arooj Ahmed, Serhan Unlu, Christopher Haddad, Aashray Mandala, Yasuo Kubota, Jaroslaw P. Maciejewski, Valeria Visconte

Blood (2023) 142 (Supplement 1): 4336.

https://doi.org/10.1182/blood-2023-184962

Published: 2023

Journal Articles

Outcomes of Venetoclax-Based Therapy in Patients with Daratumumab-Refractory t(11;14) Positive Light Chain Amyloidosis

Mark Orland, Danai Dima, Fauzia Ullah, Hussein Awada, Diana Basali, Beth M. Faiman, Cynthia Scott, Sandra Mazzoni, Louis S. Williams, Christy J. Samaras, Jason Valent, Faiz Anwer, Shahzad Raza, Jack Khouri

Blood (2023) 142 (Supplement 1): 2031.

https://doi.org/10.1182/blood-2023-183030

Published: 2023

Journal Articles

HMR Mutations Drive Poor Prognosis in Myelofibrosis Patients with Lower JAK2 V617F Allele Burden but Not in Those with Higher Allele Burden: Results of a Multicenter Study

Yu-Hung Wang, Carmelo Gurnari, Chao-Hung Wei, Hussein Awada, Chien-Chin Lin, Andrius Zucenka, Chi-Yuan Yao, Kristian Gurashi, Hsin-An Hou, Kiran Batta, Wen-Chien Chou, Jaroslaw P. Maciejewski, Daniel H Wiseman, Hwei-Fang Tien

Blood (2023) 142 (Supplement 1): 627.

https://doi.org/10.1182/blood-2023-179907

Published: 2023

Journal Articles

Thrombocytosis and Megakaryocyte Changes Associated with Pure Red Cell Aplasia

Joelle Abdallah, Robert George Williams, Ganesh Raman, Hussein Awada, Weina Chen, Carmelo Gurnari, Jaroslaw P. Maciejewski, Taha Bat

Blood (2023) 142 (Supplement 1): 5207.

https://doi.org/10.1182/blood-2023-185223

Published: 2023

Journal Articles

An Ensemble Machine Learning Model Using Gradient Boosting Identifies Patients with Disease Progression in Newly Diagnosed Multiple Myeloma

Louis S. Williams, Bardia Khosravi, Marko Velimirovic, Jack Khouri, Shahzad Raza, Sandra Mazzoni, Christy J. Samaras, Hussein Awada, Danai Dima, Jason Valent, Faiz Anwer

Blood (2023) 142 (Supplement 1): 1990.

https://doi.org/10.1182/blood-2023-188762

Published: 2023

Journal Articles

Unraveling the Impact of 2022 Classifications on Secondary Acute Myeloid Leukemia: Assessing the True Qualification Power of Diagnostic Qualifiers

Enrico Attardi, Arianna Savi, Beatrice Borsellino, Marta Cipriani, Alfonso Piciocchi, Flavia Mallegni, Giorgia Silvestrini, Hussein Awada, Arda Durmaz, Valeria Visconte, Matteo Giovanni Della Porta, Adriano Venditti, Jaroslaw P. Maciejewski, Carmelo Gurnari, Maria Teresa Voso

Blood (2023) 142 (Supplement 1): 819.

https://doi.org/10.1182/blood-2023-185709

Published: 2023

Journal Articles

Impact of Prior Lines of Therapy before Autologous Hematopoietic Cell Transplant on Survival in Standard Risk Multiple Myeloma

Hussein Awada, Ali Hajj Ali, Danai Dima, Craig S Sauter, Louis Williams, Jack Khouri, Shahzad Raza, Sandra Mazzoni, Jason Valent, Christy J. Samaras, Faiz Anwer

Blood (2023) 142 (Supplement 1): 7069.

https://doi.org/10.1182/blood-2023-189995

Published: 2023

Journal Articles

Geno-Multiomics Strategy Informs Drug Response Profiles in High-Risk Myeloid Neoplasia

Arda Durmaz, Sean Yetter, Tariq Kewan, Waled Bahaj, Carlos Bravo-Perez, Luca Guarnera, Naomi Kawashima, Hussein Awada, Carmelo Gurnari, Yasuo Kubota, Jacob Scott, Jaroslaw P. Maciejewski, Valeria Visconte

Blood (2023) 142 (Supplement 1): 5016.

https://doi.org/10.1182/blood-2023-190059

Published: 2023

Journal Articles

Predicting Clonal Evolution to Secondary Myeloid Neoplasms in Aplastic Anemia through Machine Learning

Ahmet Celal Toprak, Taha Bat, Mutlu Mete, Carmelo Gurnari, Zoe Bass, Jaroslaw P. Maciejewski, Hussein Awada, Alper Olcal, Ibrahim F. Ibrahim

Blood (2023) 142 (Supplement 1): 4093.

https://doi.org/10.1182/blood-2023-191141

Published: 2023

Journal Articles

Outcome Prediction in DDX41 -Mutant Myelodysplastic Syndromes Is Not Possible with General Disease Schemes and Requires a Dedicated Risk Scoring System

Carmelo Gurnari, Hideki Makishima, Arda Durmaz, Ryunosuke Saiki, Guilherme Mendes Sapinho, Alex Bataller, Lukasz P. Gondek, Yasuhito Nannya, Steve Best, Pramila Krishnamurthy, Hussein Awada, Enrico Attardi, Valeria Visconte, Maria Teresa Voso, Amy E. DeZern, Guillermo Garcia-Manero, Austin Kulasekararaj, Jaroslaw P. Maciejewski, Seishi Ogawa

Blood (2023) 142 (Supplement 1): 316.

https://doi.org/10.1182/blood-2023-178116

Published: 2023

Journal Articles

Outcomes of Salvage VDT-PACE-like Regimens in Relapsed-Refractory Multiple Myeloma: 10-Year Experience of a Large Academic Institution

Arooj Ahmed, Danai Dima, Kerri Row, Fauzia Ullah, Hussein Awada, Diana Basali, Heena Kurish, Mikhaila Rice, Joslyn Rudoni, Marissa Duco, Beth M. Faiman, Jack Khouri, Sandra Mazzoni, Louis S. Williams, Shahzad Raza, Christy J. Samaras, Jason Valent, Faiz Anwer

Blood (2023) 142 (Supplement 1): 4724.

https://doi.org/10.1182/blood-2023-182972

Published: 2023

Journal Articles

Somatic and Germline HLA Determinants of Immune Surveillance and Escape in Myelodysplastic Syndromes

Carmelo Gurnari, Arda Durmaz, Benjamin Kroger, Hussein Awada, Jacky Chen, Colin Hercus, Sébastien Hergalant, Carlos Bravo-Perez, Maria Teresa Voso, Jacob Scott, Valeria Visconte, Stephen S. Chung, Jaroslaw P. Maciejewski, Simona Pagliuca

Blood (2023) 142 (Supplement 1): 3220.

https://doi.org/10.1182/blood-2023-178890

Published: 2023

Journal Articles

Efficacy and Safety of Idecabtagene Vicleucel (ide-cel) in Patients with Relapsed-Refractory Multiple Myeloma (RRMM) Not Meeting the Karmma Trial Eligibility Criteria: A Real-World Multicenter Study

Danai Dima, Aliya Rashid, James A Davis, Hussein Awada, Al-Ola Abdallah, Hong Li, Shaun DeJarnette, Leyla Shune, Jack Khouri, Hamza Hashmi, Joseph P McGuirk, Faiz Anwer, Nausheen Ahmed

Blood (2023) 142 (Supplement 1): 4885.

https://doi.org/10.1182/blood-2023-180368

Published: 2023

Journal Articles

Lessons of Nature in Trisomy-8 MDS and AML: Determinants of Clonal Drive

Hussein Awada, Yasuo Kubota, Carmelo Gurnari, Carlos Bravo-Perez, Serhan Unlu, Luca Guarnera, Danai Dima, Arda Durmaz, Hassan Awada, Jaroslaw P. Maciejewski, Valeria Visconte

Blood (2023) 142 (Supplement 1): 5707.

https://doi.org/10.1182/blood-2023-190773

Published: 2023

Journal Articles

Deciphering Treatment Patterns in Non-Severe Aplastic Anemia: An International Observational Study

Bruno Fattizzo, Carmelo Gurnari, Giulio Cassanello, Marta Bortolotti, Hussein Awada, Sabrina Giammarco, Dario Consonni, Simona Sica, Shreyans Gandhi, Roochi Trikha, Jaroslaw P. Maciejewski, Austin Kulasekararaj, Wilma Barcellini

Blood (2022) 140 (Supplement 1): 8638–8640.

https://doi.org/10.1182/blood-2022-166347

Published: 2022

Journal Articles

Chip-Derived Vs De Novo Treatment-Related Myeloid Neoplasms after Autologous Stem Cell Transplant for Lymphoid Disorders

Hussein Awada, Carmelo Gurnari, Valeria Visconte, Teodora Kuzmanovic, Hassan Awada, James R. Cook, David S. Bosler, Brian J. Bolwell, Ronald M. Sobecks, Matt Kalaycio, Jaroslaw P. Maciejewski

Blood (2022) 140 (Supplement 1): 298–299.

https://doi.org/10.1182/blood-2022-167886

Published: 2022

Journal Articles

The Role of Corrected Dlco in Predicting Relapse and Mortality Post Autologous Hematopoietic Cell Transplantation in Multiple Myeloma

Blood (2022) 140 (Supplement 1): 10592–10593.

https://doi.org/10.1182/blood-2022-168433

Published: 2022

Journal Articles

Validation of the Gatmo Score in Predicting Mortality Following Autologous Hematopoietic Cell Transplant in Multiple Myeloma Patients

Hussein Awada, Adel Hajj Ali, Danai Dima, Lauren M. Granat, Michael Sheu, Puneet Dhillon, Mikhaila Rice, Heena P Kurish, Louis S. Williams, Faiz Anwer, Jack Khouri

Blood (2022) 140 (Supplement 1): 10583–10584.

https://doi.org/10.1182/blood-2022-165673

Published: 2022

NARROW

Paroxysmal nocturnal hemoglobinuria–related thrombosis in the era of novel therapies: a 2043-patient-year analysis

Can Emergency Hematopoiesis Due to Sepsis Lead to Clonal Hematopoiesis? Implications for Understanding the Pathogenesis of Clonal Evolution

Molecular Landscape of c-CBL Mutation in Adults' Myeloid Malignancies

Outcomes of Venetoclax-Based Therapy in Patients with Daratumumab-Refractory t(11;14) Positive Light Chain Amyloidosis

HMR Mutations Drive Poor Prognosis in Myelofibrosis Patients with Lower JAK2 V617F Allele Burden but Not in Those with Higher Allele Burden: Results of a Multicenter Study

Thrombocytosis and Megakaryocyte Changes Associated with Pure Red Cell Aplasia

An Ensemble Machine Learning Model Using Gradient Boosting Identifies Patients with Disease Progression in Newly Diagnosed Multiple Myeloma

Unraveling the Impact of 2022 Classifications on Secondary Acute Myeloid Leukemia: Assessing the True Qualification Power of Diagnostic Qualifiers

Impact of Prior Lines of Therapy before Autologous Hematopoietic Cell Transplant on Survival in Standard Risk Multiple Myeloma

Geno-Multiomics Strategy Informs Drug Response Profiles in High-Risk Myeloid Neoplasia

Predicting Clonal Evolution to Secondary Myeloid Neoplasms in Aplastic Anemia through Machine Learning

Outcome Prediction in DDX41 -Mutant Myelodysplastic Syndromes Is Not Possible with General Disease Schemes and Requires a Dedicated Risk Scoring System

Outcomes of Salvage VDT-PACE-like Regimens in Relapsed-Refractory Multiple Myeloma: 10-Year Experience of a Large Academic Institution

Somatic and Germline HLA Determinants of Immune Surveillance and Escape in Myelodysplastic Syndromes

Efficacy and Safety of Idecabtagene Vicleucel (ide-cel) in Patients with Relapsed-Refractory Multiple Myeloma (RRMM) Not Meeting the Karmma Trial Eligibility Criteria: A Real-World Multicenter Study

Lessons of Nature in Trisomy-8 MDS and AML: Determinants of Clonal Drive

Deciphering Treatment Patterns in Non-Severe Aplastic Anemia: An International Observational Study

Chip-Derived Vs De Novo Treatment-Related Myeloid Neoplasms after Autologous Stem Cell Transplant for Lymphoid Disorders

The Role of Corrected Dlco in Predicting Relapse and Mortality Post Autologous Hematopoietic Cell Transplantation in Multiple Myeloma

Validation of the Gatmo Score in Predicting Mortality Following Autologous Hematopoietic Cell Transplant in Multiple Myeloma Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only